Skip to main content
Caplight Logo









TransAlgae

TransAlgae

Private
IsraelHealthcare & Life Scienceshttps://transalgae.com

Last Round

Early Funding

Apr 1, 2021

Total Funding Raised

$13.06M

Company Overview

TransAlgae operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was an Early Funding round in April 2021.

TransAlgae is a biotechnology company that has developed a platform for the oral delivery of drugs, vaccines, and pesticides using genetically modified algae for the animal health and crop protection industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TransAlgae Comparables

Compare TransAlgae with similar companies based on industry and business-model similarity.

TransAlgae comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ViAqua Therapeutics
79%
FeedVax
79%
Sundew Bio
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TransAlgae Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Maor Sasson

CEO

Executive Team

Ofra Chen

Deputy CEO & CTO At TransAlgae

Executive Team

Zohar Rotem

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2021

    $2.5M raised with Gan Shmuel Foods Ltd. as lead investor.

Book a demo to see all signals

For institutional investors. Book with your work email.

TransAlgae Filings

Explore SEC and related filing metadata, where available.

TransAlgae filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TransAlgae's valuation, stock price, and market status.

Is TransAlgae a public or private company?

TransAlgae is a private company.

What is the current stock price of TransAlgae?

TransAlgae is a private company, so its shares have no public market price. Caplight tracks TransAlgae's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TransAlgae worth (valuation)?

Valuation information for TransAlgae is not publicly available.

Can I buy TransAlgae stock?

TransAlgae shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TransAlgae's last funding round?

TransAlgae's most recent funding round was Early Funding on April 1, 2021.

Who are the main investors in TransAlgae?

Investor information for TransAlgae is not publicly disclosed.

Will TransAlgae IPO soon?

No public IPO plans have been announced for TransAlgae.

How can I track TransAlgae secondary market activity?

Caplight tracks bids, offers, and trades in TransAlgae's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range10
Year Founded2008
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?